NKGEN Biotech
CA - Santa Ana
BiotechnologyFocus: Autologous and allogenic Natural Killer cell therapy
NKGEN Biotech is a life sciences company focused on Autologous and allogenic Natural Killer cell therapy.
Gene TherapyCell Therapy
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
SNK01
Refractory CancerClinical Trials (1)
NCT03941262Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy
Phase 1SNK01
Alzheimer DiseaseClinical Trials (1)
NCT04678453Safety of SNK01 in Subjects With Alzheimer's Disease (ASK-AD)
Phase 1Study Product: SNK01
Plaque PsoriasisClinical Trials (1)
NCT03894579Autologous Natural Killer Cells in Subjects With Plaque Psoriasis
Phase 1Clinical Trials (1)
NCT05990920Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy
Phase 1Phase 1/2
Clinical Trials (1)
NCT06189963Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease
Phase 1/2SNK01
Advanced Solid TumorClinical Trials (1)
NCT04464967Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers
Phase 1/2Phase 1/2
Clinical Trials (1)
NCT05099549Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers
Phase 1/2SNK01
Alzheimer DiseaseClinical Trials (1)
NCT07228078Open-Label Extension Protocol to SNK01-AD01 Study
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 8 clinical trials
Hiring Trend
Stable
0
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles